C. M. Tangen
All authors
About
Publications While At HealthPartners
selected publications
Journal Article
Orteronel for metastatic hormone-sensitive prostate cancer: a multicenter, randomized, open-label phase III trial (SWOG-1216)
.
Journal of Clinical Oncology.
2022
Contact
full name
C. M.
Tangen
Quick Info
Collaboration
Co-author network
Map of science